Methylation Patterns Are New Target for ctDNA Analysis

Tests that measure circulating DNA are not entirely new. Yet, until now such tests have been unable to determine the tissue of origin (other than in cases of noninvasive prenatal testing, in which DNA … [Read more...]


FDA Approves Great Basin Scientific Test for Quick Staph Identification

By Ron Shinkman, Editor, Laboratory Industry Report Salt Lake City-based Great Basin Scientific has said it has received clearance from the U.S. Food and Drug Administration for a test that provides … [Read more...]


Inflammatory Markers May Diagnose Back Conditions

Biochemical profiles of blood may improve diagnosis of conditions contributing to low back pain (LBP), according to a study published online Jan. 7 in Arthritis Research & Therapy. LBP is … [Read more...]


NGS-Based Test for CF Promises Faster, Cheaper, More Thorough Analysis

Testing for the cystic fibrosis (CF) helped to fuel the first wave of clinical molecular diagnostics. Now, an assay developed by researchers at the Stanford University taps the power of multiplex … [Read more...]


Transgenomic Announces Two New Tests for Colorectal Cancer, Melanoma

By Ron Shinkman, Editor, Laboratory Industry Report Transgenomic has released two new liquid biopsy tests for colorectal cancer and metastatic melanoma. Both panels will focus on genetic mutations … [Read more...]


Neoteryx–A Less Ambitious Version of Theranos?

A California startup has launched a platform that can gather blood in tiny tubes for assays with all but no inconvenience for patients. And it is not Theranos. Unlike that troubled Silicon Valley … [Read more...]


Veritas Launches Below-$1,000 Whole Genome Test

By Ron Shinkman, Editor, Laboratory Industry Report Veritas Genetics is launching a whole genome test under the four-figure price point. The whole genome assay is priced at $999, with interpretation … [Read more...]


Connecticut Lab Developing $200 BRCA Test

Just a few years ago, it could cost upward of $4,000 to undergo a molecular test for the BRCA gene. The prices began to drop following a 2013 U.S. Supreme Court decision that prohibited the patenting … [Read more...]


Children’s Hospital Los Angeles, Thermo Fisher to Develop NGS Pediatric Cancer Test Panel

By Ron Shinkman, Editor, Laboratory Industry Report Children's Hospital Los Angeles (CHLA) has entered into a pact with Thermo Fisher Scientific to develop a panel of next-generation sequencing tests … [Read more...]


New Molecular Test for Cystic Fibrosis Promises Faster, Better, Cheaper Analysis

By Stephanie Murg, Managing Director, G2 Intelligence The future of cystic fibrosis (CF) diagnosis is in sight. Testing for the genetic disease helped to fuel the first wave of clinical molecular … [Read more...]